SpiD3 is a novel spirocyclic dimer. SpiD3 shows antitumor effect and induces cell apoptosis in malignant B cells. SpiD3 can be used for study of chronic lymphocytic leukemia.
References:
[1]. Eiken AP, et al. Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects. Cancer Res Commun. 2024;4(5):1328-1343.
















